Hosted on MSN
Clinical Trials for Cancer: How to Sidestep the 7 Most Common Barriers to Participation
Clinical trials are widely accepted as the way to progress toward establishing new standards in cancer therapies while simultaneously offering affordable, state-of-the-art care. But few people ...
Advancing Clinical Trial Sample Management Through LIMS Development, Laboratory Operations Excellence, and Data-Driven BioTech/Biopharma Infrastructure Boston, Massachusetts — Smitha Yerrum, a ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
Clinical trial names span a broad range, from straightforward acronyms to more inspiring titles—see: Eli Lilly’s optimistically dubbed family of Triumph trials—to the downright ostentatious, like ...
The clinical trial landscape is continually adapting its focus on patient-centric practices to improve clinical trial participation by reducing patients' burden. Over the past few years, this shift ...
There's good news to report when it comes to women's health. A new study provides encouraging evidence that most clinical ...
Stakeholders ask for flexibility, more examples in FDA guidance on overall survival in cancer trials
Stakeholders asked the US Food and Drug Administration for more examples in comments on a recently issued guidance on the use of overall survival as an endpoint in oncology drug clinical trials. They ...
Discover the technologies transforming the future of clinical research, from AI and decentralized clinical trials to ...
Updated MS criteria may speed diagnosis but reshape clinical trials, increasing the need for better markers of progression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results